US$ 28.65
glp-1 agonists and sglt2 inhibitors combination Influence of therapy with receptor on the management of blood pressure in Japanese patients with diabetes Updated evidence on cardiovascular and
Description
Trials with head-to-head comparison would be necessary to demonstrate possible superiority of a drug within the GLP-1RA class

If you've received it, then you either subscribed or someone forwarded it to you

10.1016/j.drudis.2024.103910 83 WongC

Mounjaro had the first-mover advantage, said Kovil

However, it did lead to a reduction in TSH levels, in agreement with the findings of the study conducted by Kseolu et al